Exceed World, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Exceed World, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $8.62M | Jan 13, 2026 |
| FY2025 | Sep 30, 2024 | $24.38M | Jan 13, 2026 |
| FY2024 | Sep 30, 2023 | $25.92M | Jan 14, 2025 |
| FY2023 | Dec 31, 2022 | $6.03M | Feb 14, 2023 |
| FY2023 | Sep 30, 2022 | $34.69M | Jan 5, 2024 |
| FY2023 | Dec 31, 2021 | $5.04M | Feb 14, 2023 |
| FY2022 | Sep 30, 2021 | $28.43M | Jan 9, 2023 |
| FY2021 | Sep 30, 2020 | $21.02M | Jan 13, 2022 |
| FY2020 | Sep 30, 2019 | $28.39M | Jan 13, 2021 |
| FY2019 | Sep 30, 2018 | $34.88M | Mar 20, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $4.08M | Jan 13, 2026 |
| FY2025 | Sep 30, 2024 | $13.45M | Jan 13, 2026 |
| FY2024 | Sep 30, 2023 | $12.94M | Jan 14, 2025 |
| FY2023 | Dec 31, 2022 | $3.13M | Feb 14, 2023 |
| FY2023 | Sep 30, 2022 | $17.38M | Jan 5, 2024 |
| FY2023 | Dec 31, 2021 | $2.45M | Feb 14, 2023 |
| FY2022 | Sep 30, 2021 | $14.74M | Jan 9, 2023 |
| FY2021 | Sep 30, 2020 | $10.48M | Jan 13, 2022 |
| FY2020 | Sep 30, 2019 | $12.29M | Jan 13, 2021 |
| FY2019 | Sep 30, 2018 | $16.22M | Mar 20, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($6.88M) | Jan 13, 2026 |
| FY2025 | Sep 30, 2024 | $1.17M | Jan 13, 2026 |
| FY2024 | Sep 30, 2023 | ($551.7K) | Jan 14, 2025 |
| FY2023 | Dec 31, 2022 | $92.5K | Feb 14, 2023 |
| FY2023 | Sep 30, 2022 | $4.14M | Jan 5, 2024 |
| FY2023 | Dec 31, 2021 | ($669.7K) | Feb 14, 2023 |
| FY2022 | Sep 30, 2021 | $3.07M | Jan 9, 2023 |
| FY2021 | Sep 30, 2020 | ($962.3K) | Jan 13, 2022 |
| FY2020 | Sep 30, 2019 | ($132.0K) | Jan 13, 2021 |
| FY2019 | Sep 30, 2018 | $2.38M | Mar 20, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($6.87M) | Jan 13, 2026 |
| FY2025 | Sep 30, 2024 | $1.67M | Jan 13, 2026 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $17.70M | Jan 13, 2026 |
| FY2025 | Sep 30, 2024 | $25.00M | Jan 13, 2026 |
| FY2024 | Sep 30, 2023 | $23.28M | Jan 14, 2025 |
| FY2023 | Dec 31, 2022 | $27.31M | Feb 14, 2023 |
| FY2023 | Sep 30, 2022 | $28.11M | Jan 5, 2024 |
| FY2022 | Sep 30, 2021 | $28.46M | Jan 9, 2023 |
| FY2021 | Sep 30, 2020 | $25.63M | Jan 13, 2022 |
| FY2020 | Sep 30, 2019 | $25.96M | Jan 13, 2021 |
| FY2019 | Sep 30, 2018 | $29.24M | Mar 20, 2020 |
| FY2018 | Sep 30, 2017 | $21.08M | Jul 11, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $6.72M | Jan 13, 2026 |
| FY2025 | Sep 30, 2024 | $6.24M | Jan 13, 2026 |
| FY2024 | Sep 30, 2023 | $6.67M | Jan 14, 2025 |
| FY2023 | Dec 31, 2022 | $7.63M | Feb 14, 2023 |
| FY2023 | Sep 30, 2022 | $10.34M | Jan 5, 2024 |
| FY2022 | Sep 30, 2021 | $9.47M | Jan 9, 2023 |
| FY2021 | Sep 30, 2020 | $8.51M | Jan 13, 2022 |
| FY2017 | Sep 30, 2017 | $880.4K | Jan 2, 2018 |
| FY2017 | Sep 30, 2016 | $178.6K | Jan 2, 2018 |
| FY2015 | Nov 30, 2015 | $4.7K | Feb 22, 2016 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $10.98M | Jan 13, 2026 |
| FY2025 | Sep 30, 2024 | $18.77M | Jan 13, 2026 |
| FY2024 | Sep 30, 2023 | $16.61M | Jan 14, 2025 |
| FY2023 | Dec 31, 2022 | $19.68M | Feb 14, 2023 |
| FY2023 | Sep 30, 2022 | $17.77M | Jan 5, 2024 |
| FY2022 | Sep 30, 2021 | $18.98M | Jan 9, 2023 |
| FY2021 | Sep 30, 2020 | $17.12M | Jan 13, 2022 |
| FY2020 | Sep 30, 2019 | $17.78M | Jan 13, 2021 |
| FY2019 | Sep 30, 2018 | $16.83M | Mar 20, 2020 |
| FY2018 | Sep 30, 2017 | $14.66M | Jul 11, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $16.75M | Jan 13, 2026 |
| FY2025 | Sep 30, 2024 | $23.63M | Jan 13, 2026 |
| FY2024 | Sep 30, 2023 | $22.46M | Jan 14, 2025 |
| FY2023 | Dec 31, 2022 | $23.11M | Feb 14, 2023 |
| FY2023 | Sep 30, 2022 | $23.01M | Jan 5, 2024 |
| FY2022 | Sep 30, 2021 | $18.88M | Jan 9, 2023 |
| FY2021 | Sep 30, 2020 | $15.80M | Jan 13, 2022 |
| FY2020 | Sep 30, 2019 | $16.76M | Jan 13, 2021 |
| FY2019 | Sep 30, 2018 | $16.90M | Mar 20, 2020 |
| FY2018 | Sep 30, 2017 | $14.52M | Jul 11, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $7.59M | Jan 13, 2026 |
| FY2025 | Sep 30, 2024 | $18.46M | Jan 13, 2026 |
| FY2025 | Sep 30, 2023 | $18.17M | Jan 13, 2026 |
| FY2023 | Dec 31, 2022 | $23.88M | Feb 14, 2023 |
| FY2024 | Sep 30, 2022 | $23.82M | Jan 14, 2025 |
| FY2023 | Dec 31, 2021 | $19.28M | Feb 14, 2023 |
| FY2023 | Sep 30, 2021 | $23.06M | Jan 5, 2024 |
| FY2022 | Sep 30, 2020 | $19.37M | Jan 9, 2023 |
| FY2021 | Sep 30, 2019 | $20.20M | Jan 13, 2022 |
| FY2019 | Sep 30, 2018 | $22.74M | Mar 20, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Sep 30, 2018 | $483.8K | Mar 20, 2020 |
| FY2018 | Sep 30, 2017 | $489.0K | Jul 11, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 0 | Jan 13, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Jan 13, 2026 |
| FY2024 | Sep 30, 2023 | 0 | Jan 14, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Feb 14, 2023 |
| FY2023 | Sep 30, 2022 | 0 | Jan 5, 2024 |
| FY2023 | Dec 31, 2021 | 0 | Feb 14, 2023 |
| FY2022 | Sep 30, 2021 | 0 | Jan 9, 2023 |
| FY2021 | Sep 30, 2020 | 0 | Jan 13, 2022 |
| FY2020 | Sep 30, 2019 | 0 | Jan 13, 2021 |
| FY2019 | Sep 30, 2018 | 0 | Mar 20, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 0 | Jan 13, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Jan 13, 2026 |
| FY2024 | Sep 30, 2023 | 0 | Jan 14, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Feb 14, 2023 |
| FY2023 | Sep 30, 2022 | 0 | Jan 5, 2024 |
| FY2023 | Dec 31, 2021 | 0 | Feb 14, 2023 |
| FY2022 | Sep 30, 2021 | 0 | Jan 9, 2023 |
| FY2021 | Sep 30, 2020 | 0 | Jan 13, 2022 |
| FY2020 | Sep 30, 2019 | 0 | Jan 13, 2021 |
| FY2019 | Sep 30, 2018 | 0 | Mar 20, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Jan 9, 2023 | 32.70M | Jan 9, 2023 |
| FY2023 | Dec 31, 2022 | 32.70M | Feb 14, 2023 |
| FY2023 | Sep 30, 2022 | 32.70M | Feb 14, 2023 |
| FY2023 | Dec 31, 2021 | 32.70M | Feb 14, 2023 |
| FY2023 | Sep 30, 2021 | 32.70M | Feb 14, 2023 |
| FY2022 | Sep 30, 2020 | 32.70M | Jan 9, 2023 |
| FY2021 | Sep 30, 2019 | 32.70M | Jan 13, 2022 |
| FY2019 | Sep 30, 2018 | 32.70M | Mar 20, 2020 |
| FY2018 | Sep 30, 2017 | 20.00M | Jul 11, 2019 |
| FY2017 | Sep 30, 2016 | 400.00M | Jan 2, 2018 |